Actively Recruiting
Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer
Led by Peking Union Medical College Hospital · Updated on 2023-08-28
3705
Participants Needed
1
Research Sites
206 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to compare the efficacy, prognosis, health economics of different treatment modalities of mid-low rectal cancer in different centers in China, and to conduct cost utility analysis (CUA) on the treatment process of rectal cancer to explore the best treatment modality that meets the actual need of medical units in each region and at each level. The investigators hope to provide evidence-based medical suggestions for medical quality control of rectal cancer and revision of clinical guidelines, and provides a source of decision making for medical management and medical insurance.
CONDITIONS
Official Title
Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pathologically confirmed rectal adenocarcinoma
- Tumor located within 12 centimeters below the anal verge
You will not qualify if you...
- Diagnosed with distant metastasis
- Multiple primary colorectal cancers
- History of previous malignant tumors
- Pregnant or lactating women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100730
Actively Recruiting
Research Team
Y
Yi Xiao, Professor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here